ABSINasdaq

Absci Corporation

Healthcare·Oncology·Pre-clinical·Vancouver, WA, United States
OncologyImmunologyReproductive

Absci Corporation (ABSI): 3 pipeline candidates · ~14 mo cash runway. Updated within the last hour.

5.9/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway3.9

14.0 months

Financial Health9.6

D/E 0.14

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth5.9

3 candidates

Catalyst MomentumN/A

N/A

Insider Signal8.1

3 buys · 2 sells (180d)

A transparent, data-derived signal for Absci Corporationacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$1.1B

Cash

$9.7M

Quarterly Burn

$26.3M

Runway

14.0 mo

Revenue

$215K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Aug 2027
Today~15 mo out
Catalyst within runway

Pipeline (3 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

162

Total value held

$347.3M

HolderSharesValue
fmr llc22,550,997$67.7M
ark investment management llc13,726,169$41.2M
blackrock, inc.11,255,194$33.8M
state street corp7,324,858$22.0M
vanguard capital management llc5,886,640$17.7M
advanced micro devices inc5,714,285$17.1M
geode capital management, llc3,343,068$10.0M
ameriprise financial inc3,180,141$9.5M
two sigma investments, lp2,898,766$8.7M
gem investment advisors, llc2,170,863$6.5M

Showing top 10 of 162 institutional holders of Absci Corporation. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Sean McClain

Frequently asked questions

How many drug candidates are in Absci Corporation's pipeline?

Absci Corporation (ABSI) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Absci Corporation's lead drug candidate?

Absci Corporation's most advanced tracked candidate is ABS-101 (Preclinical) for TL1A in inflammatory bowel disease.

What is Absci Corporation's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Absci Corporation has approximately 14.0 months of cash runway.

What is Absci Corporation's market capitalization?

Absci Corporation's market capitalization is approximately $1.1B.

Who is the CEO of Absci Corporation?

Mr. Sean McClain is the chief executive officer of Absci Corporation (ABSI).

Get the full picture on Absci Corporation

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.